You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聖湘生物(688289.SH):2023年淨利潤同比下降81.4%
格隆匯 02-28 18:45

格隆匯2月28日丨聖湘生物(688289.SH)公佈2023年度業績快報營業總收入100,646.75萬元,同比下降84.40%,歸屬於母公司所有者的淨利潤36,023.01萬元,同比下降81.4%。公司2023年度營業總收入、營業利潤等指標同比下降超過30%,主要系國內外公共衞生防控政策變化,導致新冠核酸檢測試劑及儀器需求急劇下降,相關業務收入下降所致。2023年度歸屬於母公司的所有者權益下降1.26%,主要系公司充分重視股東的合理投資回報,實施多次利潤分配所致,2023年度累計現金分紅超4億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account